These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19111045)
1. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy. Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, micro-SPECT/CT imaging and therapeutic efficacy of (188)Re-DXR-liposome in C26 colon carcinoma ascites mice model. Chen LC; Chang CH; Yu CY; Chang YJ; Wu YH; Lee WC; Yeh CH; Lee TW; Ting G Nucl Med Biol; 2008 Nov; 35(8):883-93. PubMed ID: 19026950 [TBL] [Abstract][Full Text] [Related]
3. Dosimetric evaluation of nanotargeted (188)Re-liposome with the MIRDOSE3 and OLINDA/EXM programs. Chang CH; Chang YJ; Lee TW; Ting G; Chang KP Ann Nucl Med; 2012 Jun; 26(5):419-25. PubMed ID: 22450826 [TBL] [Abstract][Full Text] [Related]
4. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice. Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution, pharmacokinetics and imaging of (188)Re-BMEDA-labeled pegylated liposomes after intraperitoneal injection in a C26 colon carcinoma ascites mouse model. Chen LC; Chang CH; Yu CY; Chang YJ; Hsu WC; Ho CL; Yeh CH; Luo TY; Lee TW; Ting G Nucl Med Biol; 2007 May; 34(4):415-23. PubMed ID: 17499731 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model. Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220 [TBL] [Abstract][Full Text] [Related]
8. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts. Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model. Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858 [TBL] [Abstract][Full Text] [Related]
10. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy. Emfietzoglou D; Kostarelos K; Sgouros G J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Lin YY; Chang CH; Li JJ; Stabin MG; Chang YJ; Chen LC; Lin MH; Tseng YL; Lin WJ; Lee TW; Ting G; Chang CA; Chen FD; Wang HE Cancer Biother Radiopharm; 2011 Jun; 26(3):373-80. PubMed ID: 21711113 [TBL] [Abstract][Full Text] [Related]
12. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166 [TBL] [Abstract][Full Text] [Related]
13. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model. Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866 [TBL] [Abstract][Full Text] [Related]
14. Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models. Burade V; Bhowmick S; Maiti K; Zalawadia R; Ruan H; Thennati R BMC Cancer; 2017 Jun; 17(1):405. PubMed ID: 28587612 [TBL] [Abstract][Full Text] [Related]
15. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416 [TBL] [Abstract][Full Text] [Related]
16. Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model. Chang YJ; Chang CH; Chang TJ; Yu CY; Chen LC; Jan ML; Luo TY; Lee TW; Ting G Anticancer Res; 2007; 27(4B):2217-25. PubMed ID: 17695506 [TBL] [Abstract][Full Text] [Related]
17. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice. Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492 [TBL] [Abstract][Full Text] [Related]
19. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice. Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model. Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]